Skip to main content

Table 2 Demographic characteristics of women in the study separated by treatment arm for those with histology available

From: Artemether-lumefantrine to treat malaria in pregnancy is associated with reduced placental haemozoin deposition compared to quinine in a randomized controlled trial

   Quinine AL p
Age (y) Mean (SD); n 22.7 (4.6); 97 23.1 (5.3); 98 0.583
Parity Median [range]; n 1 [0-6]; 97 1 [0-7]; 98 0.818
Gravidity Median [range]; n 2 [1-7]; 97 2 [1-8]; 98 0.917
Birth weight (kg) Mean (SD); n 3.02 (0.50); 85 3.06 (0.45); 84 0.525
EGA enrolment (weeks) Mean (SD); n 23.7 (6.7); 96 24.0 (7.6); 98 0.800
Parasitaemia (per L) Geometric mean [IQR]; n 2,006 [205-5,029]; 97 1,191 [504-10,335]; 97 0.075
EGA delivery (weeks) Mean (SD); n 39.0 (3.8); 96 39.4 (2.9); 96 0.475
Days between treatment and delivery Median [range]; n 105 [1-192]; 97 91 [1-204]; 98 0.994
Haemoglobin (g/dL) Mean (SD); n 12.1 (2.4); 82 12.0 (1.9); 87 0.728
  1. AL- artemether-lumefantrine; EGA- estimated gestational age; IQR interquartile range.